Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases

Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases

Nanocarriers, and especially nanostructured lipid carriers (NLC), represent one of the most effective systems for topical drug administration. NLCs are biodegradable, biocompatible and provide a prolonged drug release. The glutamate release inhibitor Riluzole (RLZ) is a drug currently used for amyot...

Full description

Bibliographic Details
Main Authors: Agudelo, M.G (Author), Bonilla, L. (Author), Espina, M. (Author), Esteruelas, G. (Author), Filgaira, I. (Author), García, M.L (Author), Gong, R.C (Author), Llorente, X. (Author), Lopez-Ramajo, D. (Author), Manils, J. (Author), Pujol, M. (Author), Sánchez-López, E. (Author), Soler, C. (Author)
Format: Article
Language:English
Published: MDPI 2023
Subjects:
dermal administration
drug delivery system
lipid nanoparticles
nanostructured lipid carriers
psoriasis
Riluzole
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items